10x Genomics Inc. has announced a collaboration with Dana-Farber Cancer Institute to advance research in diagnostic applications of tumor single cell and spatial profiling. The partnership aims to analyze tumor samples from patients with major solid cancer types to identify biomarkers linked to treatment response, resistance, and disease progression. As part of this multi-year initiative, 10x Genomics also plans to establish a CLIA-certified laboratory to support the development of innovative diagnostic tests and enable future clinical applications of single cell and spatial technologies in precision oncology.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 10x Genomics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA60593) on January 12, 2026, and is solely responsible for the information contained therein.